Bristol Myers Squibb adds 3 drugs to TrumpRx.gov for up to 90% off.

Fox News senior medical analyst Dr. Marc Siegel has the latest on discounted products under President Donald Trump’s ‘The Bottom Line.’
INTERMEDIATE: Bristol Myers Squibb launched three drugs on TrumpRx.gov on Monday, FOX Business has learned.
Each of the three prescription drugs will be offered at deep discounts ranging from 40% to 90% off retail price.
Princeton, New Jersey-based company Sotyktu’s drug costs $7,135.55 and will be dispensed through TrumpRx.gov for $743. That represents a 90% discount on what patients were paying. Sotyktu treats adults with moderate to severe plaque psoriasis.
TWO MAJOR DRUG COMPANIES ARE THE LAST TO JOIN TRUMPRX
Bristol Myers Squibb is launching three drugs on TrumpRx.gov. (George Frey/Bloomberg via Getty Images)
Zeposia, which treats relapsing forms of multiple sclerosis, will be added at a discount of between 88% and 90%.
FOX NEWS POLL: VOTERS SOUND ALARM ON HEALTH CARE COSTS
The weekly injection for the treatment of moderate to severe arthritis, Orencia SC, will be discounted by 40% off the retail price.
A White House official said this is the latest big pharma company to offer reduced prices after tax pressure from President Donald Trump.

President Donald Trump speaks as Centers for Medicare & Medicaid Services Administrator Mehmet Oz looks on during a drug pricing event in the South Court Auditorium at the White House on Feb. 5, 2026, Washington, DC. (Nathan Howard/Getty Images)
Negotiations with pharmaceutical companies continue to be successful, as more drugs are included in the government’s database.
Bristol Myers’ additions come weeks after FOX Business reported that Amgen and GSK were added to a list of prescription drug makers offering discounts on a government website.
HOUSE GOP WANTS SKY-HIGH HEALTH INSURANCE COSTS FOR BILLIONS OF AMERICANS
Amgen offers drugs on the website that take 80% off the retail price. Amjevita has an original price of $1,484, but will be available on TrumpRx.gov for $299. The drug treats rheumatoid arthritis, psoriasis and ulcerative colitis.

GSK will take a 55% discount on Incree from the retail price. (Jeffrey Greenberg/Universal Images Group via Getty Images)
Amgen also lists Aimovig and Repatha for 62% discounts.
GSK Discounts Add up to 55% off retail price. The drug treats COPD and will be listed at $159.20.
GSK lists Arnuity, Relenza and Anoro with discounts ranging from 10% to 51%.
| A ticker | Security | Finally | Change | Change % |
|---|---|---|---|---|
| AMGN | Company AMGEN INC. | 349.00 | +0.23 |
+0.07% |
| GSK | GSK PLC data | 54.25 | +0.41 |
+0.77% |
The White House is moving forward with announcements on TrumpRx.gov as Americans look for ways to lower medical costs.
GET FOX BUSINESS ON THE GO BY CLICKING HERE
Under the Biden administration, data from the Bureau of Labor Statistics shows, the cost of prescription drugs increased by 10.4% from January 2021 to January 2025. Under the Trump administration, drug prices increased by 0.2% from January 2025 through the latest data from February 2026.



